Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096159 · ClinicalTrials.gov registry record · NA
Prophylactic Antibiotics or Placebo After Hypospadias Repair
A NA study of Hypospadias, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Active
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 2
- Study locations
NCT02096159 is a NA study of Hypospadias that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 93 participants, below the 121-participant average among 3 other Hypospadias trials with a reported enrollment target (23% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02096159, a NA study of Hypospadias, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of this study is to determine if routine use of prophylactic (preventive) antibiotics after repair of mid-to-distal hypospadias is beneficial.
Conditions Studied
Interventions
- OTHER placebo
- DRUG trimethoprim-sulfamethoxazole
Study Locations (2)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Ontario
- The Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2014-03 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02096159
The ClinicalTrials.gov registry entry for NCT02096159 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 121-participant average among 3 other Hypospadias trials with a reported enrollment target (23% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypospadias appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT02096159 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Ontario.
Frequently Asked Questions
What is clinical trial NCT02096159 about?
NCT02096159 is a clinical study titled "Prophylactic Antibiotics or Placebo After Hypospadias Repair". The primary purpose of this study is to determine if routine use of prophylactic (preventive) antibiotics after repair of mid-to-distal hypospadias is beneficial.
What is the current status of trial NCT02096159?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 93 participants. The study started on 2014-03. Estimated completion is 2025-08.
What conditions does trial NCT02096159 study?
This clinical trial studies the following conditions: Hypospadias.
What interventions are being tested in trial NCT02096159?
The interventions under investigation include: placebo (OTHER), trimethoprim-sulfamethoxazole (DRUG).
Who is sponsoring clinical trial NCT02096159?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02096159 being conducted?
This trial has 2 study locations across Illinois, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypospadias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.